- PRICING
- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
EN
E
ELVN
Enliven Therapeutics Inc
49.82
+1.06+2.17%After Hours: 50.81 +0.99 +1.99%17:29 07/02 EDT
OPEN/PREV CLOSE50.34/50.92
TODAY RANGE48.52-51.12
VOL360.44K
MARKET CAP3.48B
52 WEEK RANGE14.79-52.39
AVG VOL (3M)1.37M
% TURNOVER0.50%
TURNOVER--
P/E (TTM)-29.3333
% RANGE5.11%
EPS(TTM)-1.6633
P/E(FORWARD)-27.3333
P/B6.55
BVPS7.45
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.92B
SHARES OUTSTANDING71.42M
NEXT EARNINGS08/11-08/17
FREE FLOAT59.88M
LOT SIZE1
EX-DATE02/24/2023
News
Press Releases
Financial Reports
Profile
Dow Jones·07/01 14:12
Enliven Therapeutics Is Maintained at Buy by Stifel
Dow Jones·07/01 14:12
Enliven Therapeutics Price Target Raised to $80.00/Share From $60.00 by Stifel
Benzinga·07/01 14:02
Stifel Maintains Buy on Enliven Therapeutics, Raises Price Target to $80
TipRanks·07/01 12:30
Enliven price target raised to $80 from $60 at Stifel
Dow Jones·06/29 15:41
Enliven Therapeutics Is Maintained at Buy by Jones Trading
Benzinga·06/29 15:34
Jones Trading Maintains Buy on Enliven Therapeutics, Raises Price Target to $70
The Motley Fool·06/27 19:56
What to Know About This $345,000 Enliven Insider Sale as the Stock Soars 130%
The Motley Fool·06/27 16:23
What to Know About OrbiMed's $39 Million Enliven Therapeutics Stock Sale Amid a 130% Rally
Simply Wall St·06/26 00:26
22% Below Analyst Target, Is Enliven Therapeutics (ELVN) Fairly Valued Here
TipRanks·06/25 02:03
Major Investor Makes Bold Exit Move in Enliven Therapeutics Stock
The Motley Fool·06/24 19:32
Medical Hedge Fund Sells 281,000 Shares of Enliven Theapeutics. Is it Time to Sell ELVN?
Seeking Alpha·06/22 14:55
Enliven Therapeutics: Continuing The Pop Off; What Could Go Wrong?
Same Industry
Name/Symbol
Change%
Price